Company profile: H1
1.1 - Company Overview
Company description
- Provider of a health data platform supporting end-to-end therapeutic development for medical companies and healthcare systems. Offerings include Trial Landscape for principal investigator pools, site performance and patient diversity insights; GenosAI for querying trial data; HCP Universe to discover and engage HCPs; Precise doctor directory data; and H1 Connect for global humanitarian missions.
Products and services
- Trial Landscape: data-driven platform that delivers access to diverse principal investigator pools, site performance metrics, and patient diversity insights to accelerate market entry for therapeutic programs
- GenosAI: AI-integrated component within Trial Landscape that enables querying clinical trial data to expedite insights generation and accelerate trials for therapeutic development
- HCP Universe: enterprise-grade platform that delivers discovery and engagement with healthcare professionals, enabling medical companies and healthcare systems to connect relevant HCPs for end-to-end therapeutic development efforts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to H1
Spiral Genetics
HQ: United States
Website
- Description: Provider of advanced bioinformatics tools for population analysis, structural variant detection, and data compression. Offers the BioGraph genomics analysis platform and Anchored Assembly to accurately detect SNPs, indels, and structural variants (10bp to 100kbp) using HiSeq and MiSeq data without special library prep.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spiral Genetics company profile →
Antibodies Online
HQ: Germany
Website
- Description: Provider of a vendor-independent marketplace for antibodies, ELISA kits, and related research reagents, offering more than 1.2 million products from over 160 suppliers. Portfolio includes primary (polyclonal, monoclonal, recombinant) and secondary antibodies, lateral flow antibodies, ELISA kits, recombinant proteins, and custom antibody services with Rockland Immunochemicals, Inc., serving 2,000+ companies and research institutions in 53 countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Antibodies Online company profile →
Qumas
HQ: United States
Website
- Description: Provider of a closed-loop compliance model that standardizes and integrates common elements of compliance tasks across the organization, enabling enterprises to converge compliance programs onto a single platform to reduce compliance costs and create competitive advantage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qumas company profile →
Insitro
HQ: United States
Website
- Description: Provider of an ML-driven drug discovery platform integrating in vitro cellular and clinical data; therapeutic programs in metabolism, oncology, and neuroscience; machine learning for disease redefinition and intervention identification; aggregation of clinical and phenotypic data; automated labs generating multimodal phenotypic cellular data; and pipelines for in-house and partnered programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insitro company profile →
Belong Life
HQ: United States
Website
- Description: Provider of a free patient navigation app and disease-specific social networks for cancer and multiple sclerosis, enabling patients, caregivers, and healthcare professionals to connect and manage care. Solutions include a conversational AI cancer mentor, an AI clinical trials matching assistant, and a platform for healthcare organizations to create and manage online patient communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Belong Life company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for H1
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to H1
2.2 - Growth funds investing in similar companies to H1
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for H1
4.2 - Public trading comparable groups for H1
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →